       Releases                                                                                                                                           09 22 2005 Kerry Introduces Plan to Combat Global HIV AIDS  Neglected Diseases                                                                                                                                                                                                                                                                                                                                                    WASHINGTON   Senator John Kerry  D Mass   has introduced legislation that will provide incentives for vaccine development to stop the spread of HIV AIDS  tuberculoses and malaria around the world         Kerry s Vaccines for the New Millennium Act of 2005 provides incentives for pharmaceutical and biotechnology companies to accelerate their efforts to develop vaccines and microbicides to prevent HIV AIDS  tuberculoses  malaria and other infectious diseases          With HIV AIDS  TB and malaria killing over 5 million people each year  it is vital that we stop and begin to reverse the spread of these diseases today   Senator Kerry said   Vaccines and microbicides are our greatest weapons in the fight against these deadly diseases  and it s the pharmaceutical and biotech companies who hold the key to our success  It s time we tap into our ingenuity and develop these technologies for our neighbors in the developing world   This isn t just a question of our science  it s a question of our humanity and global security          Kerry authored the legislation  which is co sponsored by Senate Foreign Relations Committee Chairman Richard Lugar  R Ind     It builds upon the Vaccines for the New Millennium Act of 2001 legislation Kerry introduced with Senator Bill Frist  R Tenn          The Kerry Lugar Vaccines for the New Millennium Act of 2005         Encourages the U S  government to work with other governments and global organizations to establish economic and other incentives for the development of vaccines  including through the establishment of advanced market commitments  AMCs          Mandates that the Secretary of the Treasury enter into negotiations with the World Bank  the International Development Association  the Global Alliance for Vaccines and Immunizations  and other interested parties to establish advanced market commitments  AMCs  to create a market incentive for the purchase of vaccines and microbicides         Offers a variety of tax incentives to large pharmaceutical and small private sector companies to encourage vaccine development  The bill provides a 30  tax credit each year on qualified research expenses  provides a refundable tax credit to small biotechnology companies based on the amount of research they do each year  and provides a 100  tax credit on contracts and other arrangements for research and development of these vaccines          Provides a 100  tax credit to companies on the sale and distribution of vaccines and microbicides if made to a qualified international health organization or foreign government for distribution in developing countries         Establishes a pilot program to encourage vaccine research under the auspices of Small Business Innovation Research  SBIR  and Small Business Technology Transfer  STTR  programs in U S  government agencies with a global heath or disease prevention mission      David Wade and April Boyd                                                                                                                                                                                                 20510                                                                                                                                                                                          Contact           Sitemap            